36 participants
Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2011-06-23
- Start Date:
- 2010-09-30
- Completion:
- 2010-12-31
Conditions
- Nonalcoholic Steatohepatitis
Interventions
- DRUG
No Results Yet